vers la météo de la validation par utilisateur
+---------------------------------------------COMP:V-N(In)---------------------------------------------+ | +-----------------SUBJ:V-N----------------+ +--MOD_ATT:N-ADJ--+ +-------COMP:N-N(of)-------+ +----------------------OBJ:V-N----------------------+ | +MOD_ATT:N-+-------APPOS------+ +--MOD_ATT:N-N--+ | +-MOD_ATT:N-ADJ+ | +--------OBJ:V-N--------+ | | | +MOD_+ +MOD_ATT:+ | +MOD_ATT:+ | | +MOD_AT+SUBJ:V-N+ +COMP:V-N(by+ +MOD_ATT+SUBJ:+ +MOD_ATT+ | | | | | | | | | | | | | | | | | | | | | In __SP__ glioma cell lines , Sb202190 decreases ( in a dose dependent manner ) expression of __SP__ __NODE__ mRNA that is increased by agonist monoclonal anti __SP__ __NODE__ protein antibody . MOD_ATT:N-ADJ (line,__SP__) MOD_ATT:N-N (line,glioma) MOD_ATT:N-N (line,cell) APPOS (line,decrease) MOD_ATT:N-N (decrease,Sb202190) MOD_ATT:N-N (manner,dose) MOD_ATT:N-N (manner,dependent) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (be,mRNA) COMP:V-N(In) (increase,line) SUBJ:V-N (increase,expression) COMP:V-N(by) (increase,agonist) OBJ:V-N (increase,protein) MOD_ATT:N-ADJ (anti,monoclonal) OBJ:V-N (__SP__,agonist) SUBJ:V-N (__SP__,anti) MOD_ATT:N-ADJ (protein,__NODE__)
+---------------------------------------------COMP:V-N(In)---------------------------------------------+ | +-----------------SUBJ:V-N----------------+ +--MOD_ATT:N-ADJ--+ +-------COMP:N-N(of)-------+ +----------------------OBJ:V-N----------------------+ | +MOD_ATT:N-+-------APPOS------+ +--MOD_ATT:N-N--+ | +-MOD_ATT:N-ADJ+ | +--------OBJ:V-N--------+ | | | +MOD_+ +MOD_ATT:+ | +MOD_ATT:+ | | +MOD_AT+ +COMP:V-N(by+ +MOD_ATT+SUBJ:+ +MOD_ATT+ | | | | | | | | | | | | | | | | | | | | In __SP__ glioma cell lines , Sb202190 decreases ( in a dose dependent manner ) expression of __SP__ __NODE__ mRNA that is increased by agonist monoclonal anti __SP__ __NODE__ protein antibody . MOD_ATT:N-ADJ (line,__SP__) MOD_ATT:N-N (line,glioma) MOD_ATT:N-N (line,cell) APPOS (line,decrease) MOD_ATT:N-N (decrease,Sb202190) MOD_ATT:N-N (manner,dose) MOD_ATT:N-N (manner,dependent) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:V-N(In) (increase,line) SUBJ:V-N (increase,expression) COMP:V-N(by) (increase,agonist) OBJ:V-N (increase,protein) MOD_ATT:N-ADJ (anti,monoclonal) OBJ:V-N (__SP__,agonist) SUBJ:V-N (__SP__,anti) MOD_ATT:N-ADJ (protein,__NODE__)
+---------------------------------------------COMP:V-N(In)---------------------------------------------+ | +-----------------SUBJ:V-N----------------+ | +--------------SUBJ:V-N-------------+ | +--MOD_ATT:N-ADJ--+ +-------COMP:N-N(of)-------+ | +----------------------OBJ:V-N----------------------+ | +MOD_ATT:N-+-------APPOS------+ +--MOD_ATT:N-N--+ | +-MOD_ATT:N-ADJ+ | | +--------OBJ:V-N--------+ | | | +MOD_+ +MOD_ATT:+ | +MOD_ATT:+ | | +MOD_AT+ | +COMP:V-N(by+ +MOD_ATT+SUBJ:+ +MOD_ATT+ | | | | | | | | | | | | | | | | | | | | | In __SP__ glioma cell lines , Sb202190 decreases ( in a dose dependent manner ) expression of __SP__ __NODE__ mRNA that is increased by agonist monoclonal anti __SP__ __NODE__ protein antibody . MOD_ATT:N-ADJ (line,__SP__) MOD_ATT:N-N (line,glioma) MOD_ATT:N-N (line,cell) APPOS (line,decrease) MOD_ATT:N-N (decrease,Sb202190) MOD_ATT:N-N (manner,dose) MOD_ATT:N-N (manner,dependent) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (be,expression) COMP:V-N(In) (increase,line) SUBJ:V-N (increase,expression) COMP:V-N(by) (increase,agonist) OBJ:V-N (increase,protein) MOD_ATT:N-ADJ (anti,monoclonal) OBJ:V-N (__SP__,agonist) SUBJ:V-N (__SP__,anti) MOD_ATT:N-ADJ (protein,__NODE__)
+---------------------------------------------COMP:V-N(In)---------------------------------------------+ | +-----------------SUBJ:V-N----------------+----------------------OBJ:V-N----------------------+ +--MOD_ATT:N-ADJ--+ +-------COMP:N-N(of)-------+ +---------COMP:V-N(by)--------+ | | +MOD_ATT:N-+-------APPOS------+ +--MOD_ATT:N-N--+ | +-MOD_ATT:N-ADJ+ | +---MOD_ATT:N-N---+ +-MOD_ATT:N-ADJ-+ | | +MOD_+ +MOD_ATT:+ | +MOD_ATT:+ | | +MOD_AT+SUBJ:V-N+ | | +MOD_ATT+ | +MOD_ATT+ | | | | | | | | | | | | | | | | | | | | | In __SP__ glioma cell lines , Sb202190 decreases ( in a dose dependent manner ) expression of __SP__ __NODE__ mRNA that is increased by agonist monoclonal anti __SP__ __NODE__ protein antibody . MOD_ATT:N-ADJ (line,__SP__) MOD_ATT:N-N (line,glioma) MOD_ATT:N-N (line,cell) APPOS (line,decrease) MOD_ATT:N-N (decrease,Sb202190) MOD_ATT:N-N (manner,dose) MOD_ATT:N-N (manner,dependent) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (be,mRNA) COMP:V-N(In) (increase,line) SUBJ:V-N (increase,expression) COMP:V-N(by) (increase,anti) OBJ:V-N (increase,protein) MOD_ATT:N-N (anti,agonist) MOD_ATT:N-ADJ (anti,monoclonal) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__)
+---------------------------------------------COMP:V-N(In)---------------------------------------------+ | +-----------------SUBJ:V-N----------------+----------------------OBJ:V-N----------------------+ +--MOD_ATT:N-ADJ--+ +-------COMP:N-N(of)-------+ +---------COMP:V-N(by)--------+ | | +MOD_ATT:N-+-------APPOS------+ +--MOD_ATT:N-N--+ | +-MOD_ATT:N-ADJ+ | +---MOD_ATT:N-N---+ +-MOD_ATT:N-ADJ-+ | | +MOD_+ +MOD_ATT:+ | +MOD_ATT:+ | | +MOD_AT+ | | +MOD_ATT+ | +MOD_ATT+ | | | | | | | | | | | | | | | | | | | | In __SP__ glioma cell lines , Sb202190 decreases ( in a dose dependent manner ) expression of __SP__ __NODE__ mRNA that is increased by agonist monoclonal anti __SP__ __NODE__ protein antibody . MOD_ATT:N-ADJ (line,__SP__) MOD_ATT:N-N (line,glioma) MOD_ATT:N-N (line,cell) APPOS (line,decrease) MOD_ATT:N-N (decrease,Sb202190) MOD_ATT:N-N (manner,dose) MOD_ATT:N-N (manner,dependent) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:V-N(In) (increase,line) SUBJ:V-N (increase,expression) COMP:V-N(by) (increase,anti) OBJ:V-N (increase,protein) MOD_ATT:N-N (anti,agonist) MOD_ATT:N-ADJ (anti,monoclonal) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__)
+---------------------------------------------COMP:V-N(In)---------------------------------------------+----------------------OBJ:V-N----------------------+ | +-----------------SUBJ:V-N----------------+------------COMP:V-N(by)-----------+ | +--MOD_ATT:N-ADJ--+ +-------COMP:N-N(of)-------+ | +------MOD_ATT:N-N------+ | | +MOD_ATT:N-+-------APPOS------+ +--MOD_ATT:N-N--+ | +-MOD_ATT:N-ADJ+ | | +MOD_ATT:N-ADJ+ | | | +MOD_+ +MOD_ATT:+ | +MOD_ATT:+ | | +MOD_AT+SUBJ:V-N+ | | | +MOD_A+ +MOD_ATT+ | | | | | | | | | | | | | | | | | | | | | In __SP__ glioma cell lines , Sb202190 decreases ( in a dose dependent manner ) expression of __SP__ __NODE__ mRNA that is increased by agonist monoclonal anti __SP__ __NODE__ protein antibody . MOD_ATT:N-ADJ (line,__SP__) MOD_ATT:N-N (line,glioma) MOD_ATT:N-N (line,cell) APPOS (line,decrease) MOD_ATT:N-N (decrease,Sb202190) MOD_ATT:N-N (manner,dose) MOD_ATT:N-N (manner,dependent) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (be,mRNA) COMP:V-N(In) (increase,line) SUBJ:V-N (increase,expression) COMP:V-N(by) (increase,__SP__) OBJ:V-N (increase,protein) MOD_ATT:N-N (__SP__,agonist) MOD_ATT:N-ADJ (__SP__,monoclonal) MOD_ATT:N-N (__SP__,anti) MOD_ATT:N-ADJ (protein,__NODE__)
+---------------------------------------------COMP:V-N(In)---------------------------------------------+----------------------OBJ:V-N----------------------+ | +-----------------SUBJ:V-N----------------+------------COMP:V-N(by)-----------+ | +--MOD_ATT:N-ADJ--+ +-------COMP:N-N(of)-------+ | +------MOD_ATT:N-N------+ | | +MOD_ATT:N-+-------APPOS------+ +--MOD_ATT:N-N--+ | +-MOD_ATT:N-ADJ+ | | +MOD_ATT:N-ADJ+ | | | +MOD_+ +MOD_ATT:+ | +MOD_ATT:+ | | +MOD_AT+ | | | +MOD_A+ +MOD_ATT+ | | | | | | | | | | | | | | | | | | | | In __SP__ glioma cell lines , Sb202190 decreases ( in a dose dependent manner ) expression of __SP__ __NODE__ mRNA that is increased by agonist monoclonal anti __SP__ __NODE__ protein antibody . MOD_ATT:N-ADJ (line,__SP__) MOD_ATT:N-N (line,glioma) MOD_ATT:N-N (line,cell) APPOS (line,decrease) MOD_ATT:N-N (decrease,Sb202190) MOD_ATT:N-N (manner,dose) MOD_ATT:N-N (manner,dependent) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:V-N(In) (increase,line) SUBJ:V-N (increase,expression) COMP:V-N(by) (increase,__SP__) OBJ:V-N (increase,protein) MOD_ATT:N-N (__SP__,agonist) MOD_ATT:N-ADJ (__SP__,monoclonal) MOD_ATT:N-N (__SP__,anti) MOD_ATT:N-ADJ (protein,__NODE__)
+---------------------------------------------COMP:V-N(In)---------------------------------------------+ | +-----------------SUBJ:V-N----------------+ | +--------------SUBJ:V-N-------------+ +----------------------OBJ:V-N----------------------+ +--MOD_ATT:N-ADJ--+ +-------COMP:N-N(of)-------+ | +---------COMP:V-N(by)--------+ | | +MOD_ATT:N-+-------APPOS------+ +--MOD_ATT:N-N--+ | +-MOD_ATT:N-ADJ+ | | +---MOD_ATT:N-N---+ +-MOD_ATT:N-ADJ-+ | | +MOD_+ +MOD_ATT:+ | +MOD_ATT:+ | | +MOD_AT+ | | | +MOD_ATT+ | +MOD_ATT+ | | | | | | | | | | | | | | | | | | | | | In __SP__ glioma cell lines , Sb202190 decreases ( in a dose dependent manner ) expression of __SP__ __NODE__ mRNA that is increased by agonist monoclonal anti __SP__ __NODE__ protein antibody . MOD_ATT:N-ADJ (line,__SP__) MOD_ATT:N-N (line,glioma) MOD_ATT:N-N (line,cell) APPOS (line,decrease) MOD_ATT:N-N (decrease,Sb202190) MOD_ATT:N-N (manner,dose) MOD_ATT:N-N (manner,dependent) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (be,expression) COMP:V-N(In) (increase,line) SUBJ:V-N (increase,expression) COMP:V-N(by) (increase,anti) OBJ:V-N (increase,protein) MOD_ATT:N-N (anti,agonist) MOD_ATT:N-ADJ (anti,monoclonal) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__)
+---------------------------------------------COMP:V-N(In)---------------------------------------------+ | +-----------------SUBJ:V-N----------------+----------------------OBJ:V-N----------------------+ | +--------------SUBJ:V-N-------------+ +------------COMP:V-N(by)-----------+ | +--MOD_ATT:N-ADJ--+ +-------COMP:N-N(of)-------+ | | +------MOD_ATT:N-N------+ | | +MOD_ATT:N-+-------APPOS------+ +--MOD_ATT:N-N--+ | +-MOD_ATT:N-ADJ+ | | | +MOD_ATT:N-ADJ+ | | | +MOD_+ +MOD_ATT:+ | +MOD_ATT:+ | | +MOD_AT+ | | | | +MOD_A+ +MOD_ATT+ | | | | | | | | | | | | | | | | | | | | | In __SP__ glioma cell lines , Sb202190 decreases ( in a dose dependent manner ) expression of __SP__ __NODE__ mRNA that is increased by agonist monoclonal anti __SP__ __NODE__ protein antibody . MOD_ATT:N-ADJ (line,__SP__) MOD_ATT:N-N (line,glioma) MOD_ATT:N-N (line,cell) APPOS (line,decrease) MOD_ATT:N-N (decrease,Sb202190) MOD_ATT:N-N (manner,dose) MOD_ATT:N-N (manner,dependent) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (be,expression) COMP:V-N(In) (increase,line) SUBJ:V-N (increase,expression) COMP:V-N(by) (increase,__SP__) OBJ:V-N (increase,protein) MOD_ATT:N-N (__SP__,agonist) MOD_ATT:N-ADJ (__SP__,monoclonal) MOD_ATT:N-N (__SP__,anti) MOD_ATT:N-ADJ (protein,__NODE__)
+---------------------------------------------COMP:V-N(In)---------------------------------------------+ | +-----------------SUBJ:V-N----------------+ +--MOD_ATT:N-ADJ--+ +-------COMP:N-N(of)-------+ +----------------------OBJ:V-N----------------------+ | +MOD_ATT:N-+-------APPOS------+ +--MOD_ATT:N-N--+ | +-MOD_ATT:N-ADJ+ | +--------OBJ:V-N--------+ | | | +MOD_+ +MOD_ATT:+ | +MOD_ATT:+ | | +MOD_AT+SUBJ:V-N+ +COMP:V-N(by+ +MOD_ATT+SUBJ:+ +MOD_ATT+ | | | | | | | | | | | | | | | | | | | | | In __SP__ glioma cell lines , Sb202190 decreases ( in a dose dependent manner ) expression of __SP__ __NODE__ mRNA that is increased by agonist monoclonal anti __SP__ __NODE__ protein antibody . MOD_ATT:N-ADJ (line,__SP__) MOD_ATT:N-N (line,glioma) MOD_ATT:N-N (line,cell) APPOS (line,decrease) MOD_ATT:N-N (decrease,Sb202190) MOD_ATT:N-N (manner,dose) MOD_ATT:N-ADJ (manner,dependent) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (be,mRNA) COMP:V-N(In) (increase,line) SUBJ:V-N (increase,expression) COMP:V-N(by) (increase,agonist) OBJ:V-N (increase,protein) MOD_ATT:N-ADJ (anti,monoclonal) OBJ:V-N (__SP__,agonist) SUBJ:V-N (__SP__,anti) MOD_ATT:N-ADJ (protein,__NODE__)
+---------------------------------------------COMP:V-N(In)---------------------------------------------+ | +-----------------SUBJ:V-N----------------+ +--MOD_ATT:N-ADJ--+ +-------COMP:N-N(of)-------+ +----------------------OBJ:V-N----------------------+ | +MOD_ATT:N-+-------APPOS------+ +--MOD_ATT:N-N--+ | +-MOD_ATT:N-ADJ+ | +--------OBJ:V-N--------+ | | | +MOD_+ +MOD_ATT:+ | +MOD_ATT:+ | | +MOD_AT+ +COMP:V-N(by+ +MOD_ATT+SUBJ:+ +MOD_ATT+ | | | | | | | | | | | | | | | | | | | | In __SP__ glioma cell lines , Sb202190 decreases ( in a dose dependent manner ) expression of __SP__ __NODE__ mRNA that is increased by agonist monoclonal anti __SP__ __NODE__ protein antibody . MOD_ATT:N-ADJ (line,__SP__) MOD_ATT:N-N (line,glioma) MOD_ATT:N-N (line,cell) APPOS (line,decrease) MOD_ATT:N-N (decrease,Sb202190) MOD_ATT:N-N (manner,dose) MOD_ATT:N-ADJ (manner,dependent) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:V-N(In) (increase,line) SUBJ:V-N (increase,expression) COMP:V-N(by) (increase,agonist) OBJ:V-N (increase,protein) MOD_ATT:N-ADJ (anti,monoclonal) OBJ:V-N (__SP__,agonist) SUBJ:V-N (__SP__,anti) MOD_ATT:N-ADJ (protein,__NODE__)
+---------------------------------------------COMP:V-N(In)---------------------------------------------+ | +-----------------SUBJ:V-N----------------+ | +--------------SUBJ:V-N-------------+ | +--MOD_ATT:N-ADJ--+ +-------COMP:N-N(of)-------+ | +----------------------OBJ:V-N----------------------+ | +MOD_ATT:N-+-------APPOS------+ +--MOD_ATT:N-N--+ | +-MOD_ATT:N-ADJ+ | | +--------OBJ:V-N--------+ | | | +MOD_+ +MOD_ATT:+ | +MOD_ATT:+ | | +MOD_AT+ | +COMP:V-N(by+ +MOD_ATT+SUBJ:+ +MOD_ATT+ | | | | | | | | | | | | | | | | | | | | | In __SP__ glioma cell lines , Sb202190 decreases ( in a dose dependent manner ) expression of __SP__ __NODE__ mRNA that is increased by agonist monoclonal anti __SP__ __NODE__ protein antibody . MOD_ATT:N-ADJ (line,__SP__) MOD_ATT:N-N (line,glioma) MOD_ATT:N-N (line,cell) APPOS (line,decrease) MOD_ATT:N-N (decrease,Sb202190) MOD_ATT:N-N (manner,dose) MOD_ATT:N-ADJ (manner,dependent) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (be,expression) COMP:V-N(In) (increase,line) SUBJ:V-N (increase,expression) COMP:V-N(by) (increase,agonist) OBJ:V-N (increase,protein) MOD_ATT:N-ADJ (anti,monoclonal) OBJ:V-N (__SP__,agonist) SUBJ:V-N (__SP__,anti) MOD_ATT:N-ADJ (protein,__NODE__)
+---------------------------------------------COMP:V-N(In)---------------------------------------------+ | +-----------------SUBJ:V-N----------------+----------------------OBJ:V-N----------------------+ +--MOD_ATT:N-ADJ--+ +-------COMP:N-N(of)-------+ +---------COMP:V-N(by)--------+ | | +MOD_ATT:N-+-------APPOS------+ +--MOD_ATT:N-N--+ | +-MOD_ATT:N-ADJ+ | +---MOD_ATT:N-N---+ +-MOD_ATT:N-ADJ-+ | | +MOD_+ +MOD_ATT:+ | +MOD_ATT:+ | | +MOD_AT+SUBJ:V-N+ | | +MOD_ATT+ | +MOD_ATT+ | | | | | | | | | | | | | | | | | | | | | In __SP__ glioma cell lines , Sb202190 decreases ( in a dose dependent manner ) expression of __SP__ __NODE__ mRNA that is increased by agonist monoclonal anti __SP__ __NODE__ protein antibody . MOD_ATT:N-ADJ (line,__SP__) MOD_ATT:N-N (line,glioma) MOD_ATT:N-N (line,cell) APPOS (line,decrease) MOD_ATT:N-N (decrease,Sb202190) MOD_ATT:N-N (manner,dose) MOD_ATT:N-ADJ (manner,dependent) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (be,mRNA) COMP:V-N(In) (increase,line) SUBJ:V-N (increase,expression) COMP:V-N(by) (increase,anti) OBJ:V-N (increase,protein) MOD_ATT:N-N (anti,agonist) MOD_ATT:N-ADJ (anti,monoclonal) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__)
+---------------------------------------------COMP:V-N(In)---------------------------------------------+ | +-----------------SUBJ:V-N----------------+----------------------OBJ:V-N----------------------+ +--MOD_ATT:N-ADJ--+ +-------COMP:N-N(of)-------+ +---------COMP:V-N(by)--------+ | | +MOD_ATT:N-+-------APPOS------+ +--MOD_ATT:N-N--+ | +-MOD_ATT:N-ADJ+ | +---MOD_ATT:N-N---+ +-MOD_ATT:N-ADJ-+ | | +MOD_+ +MOD_ATT:+ | +MOD_ATT:+ | | +MOD_AT+ | | +MOD_ATT+ | +MOD_ATT+ | | | | | | | | | | | | | | | | | | | | In __SP__ glioma cell lines , Sb202190 decreases ( in a dose dependent manner ) expression of __SP__ __NODE__ mRNA that is increased by agonist monoclonal anti __SP__ __NODE__ protein antibody . MOD_ATT:N-ADJ (line,__SP__) MOD_ATT:N-N (line,glioma) MOD_ATT:N-N (line,cell) APPOS (line,decrease) MOD_ATT:N-N (decrease,Sb202190) MOD_ATT:N-N (manner,dose) MOD_ATT:N-ADJ (manner,dependent) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:V-N(In) (increase,line) SUBJ:V-N (increase,expression) COMP:V-N(by) (increase,anti) OBJ:V-N (increase,protein) MOD_ATT:N-N (anti,agonist) MOD_ATT:N-ADJ (anti,monoclonal) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__)
+---------------------------------------------COMP:V-N(In)---------------------------------------------+----------------------OBJ:V-N----------------------+ | +-----------------SUBJ:V-N----------------+------------COMP:V-N(by)-----------+ | +--MOD_ATT:N-ADJ--+ +-------COMP:N-N(of)-------+ | +------MOD_ATT:N-N------+ | | +MOD_ATT:N-+-------APPOS------+ +--MOD_ATT:N-N--+ | +-MOD_ATT:N-ADJ+ | | +MOD_ATT:N-ADJ+ | | | +MOD_+ +MOD_ATT:+ | +MOD_ATT:+ | | +MOD_AT+SUBJ:V-N+ | | | +MOD_A+ +MOD_ATT+ | | | | | | | | | | | | | | | | | | | | | In __SP__ glioma cell lines , Sb202190 decreases ( in a dose dependent manner ) expression of __SP__ __NODE__ mRNA that is increased by agonist monoclonal anti __SP__ __NODE__ protein antibody . MOD_ATT:N-ADJ (line,__SP__) MOD_ATT:N-N (line,glioma) MOD_ATT:N-N (line,cell) APPOS (line,decrease) MOD_ATT:N-N (decrease,Sb202190) MOD_ATT:N-N (manner,dose) MOD_ATT:N-ADJ (manner,dependent) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (be,mRNA) COMP:V-N(In) (increase,line) SUBJ:V-N (increase,expression) COMP:V-N(by) (increase,__SP__) OBJ:V-N (increase,protein) MOD_ATT:N-N (__SP__,agonist) MOD_ATT:N-ADJ (__SP__,monoclonal) MOD_ATT:N-N (__SP__,anti) MOD_ATT:N-ADJ (protein,__NODE__)
+---------------------------------------------COMP:V-N(In)---------------------------------------------+----------------------OBJ:V-N----------------------+ | +-----------------SUBJ:V-N----------------+------------COMP:V-N(by)-----------+ | +--MOD_ATT:N-ADJ--+ +-------COMP:N-N(of)-------+ | +------MOD_ATT:N-N------+ | | +MOD_ATT:N-+-------APPOS------+ +--MOD_ATT:N-N--+ | +-MOD_ATT:N-ADJ+ | | +MOD_ATT:N-ADJ+ | | | +MOD_+ +MOD_ATT:+ | +MOD_ATT:+ | | +MOD_AT+ | | | +MOD_A+ +MOD_ATT+ | | | | | | | | | | | | | | | | | | | | In __SP__ glioma cell lines , Sb202190 decreases ( in a dose dependent manner ) expression of __SP__ __NODE__ mRNA that is increased by agonist monoclonal anti __SP__ __NODE__ protein antibody . MOD_ATT:N-ADJ (line,__SP__) MOD_ATT:N-N (line,glioma) MOD_ATT:N-N (line,cell) APPOS (line,decrease) MOD_ATT:N-N (decrease,Sb202190) MOD_ATT:N-N (manner,dose) MOD_ATT:N-ADJ (manner,dependent) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:V-N(In) (increase,line) SUBJ:V-N (increase,expression) COMP:V-N(by) (increase,__SP__) OBJ:V-N (increase,protein) MOD_ATT:N-N (__SP__,agonist) MOD_ATT:N-ADJ (__SP__,monoclonal) MOD_ATT:N-N (__SP__,anti) MOD_ATT:N-ADJ (protein,__NODE__)
+---------------------------------------------COMP:V-N(In)---------------------------------------------+ | +-----------------SUBJ:V-N----------------+ | +--------------SUBJ:V-N-------------+ +----------------------OBJ:V-N----------------------+ +--MOD_ATT:N-ADJ--+ +-------COMP:N-N(of)-------+ | +---------COMP:V-N(by)--------+ | | +MOD_ATT:N-+-------APPOS------+ +--MOD_ATT:N-N--+ | +-MOD_ATT:N-ADJ+ | | +---MOD_ATT:N-N---+ +-MOD_ATT:N-ADJ-+ | | +MOD_+ +MOD_ATT:+ | +MOD_ATT:+ | | +MOD_AT+ | | | +MOD_ATT+ | +MOD_ATT+ | | | | | | | | | | | | | | | | | | | | | In __SP__ glioma cell lines , Sb202190 decreases ( in a dose dependent manner ) expression of __SP__ __NODE__ mRNA that is increased by agonist monoclonal anti __SP__ __NODE__ protein antibody . MOD_ATT:N-ADJ (line,__SP__) MOD_ATT:N-N (line,glioma) MOD_ATT:N-N (line,cell) APPOS (line,decrease) MOD_ATT:N-N (decrease,Sb202190) MOD_ATT:N-N (manner,dose) MOD_ATT:N-ADJ (manner,dependent) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (be,expression) COMP:V-N(In) (increase,line) SUBJ:V-N (increase,expression) COMP:V-N(by) (increase,anti) OBJ:V-N (increase,protein) MOD_ATT:N-N (anti,agonist) MOD_ATT:N-ADJ (anti,monoclonal) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__)
+---------------------------------------------COMP:V-N(In)---------------------------------------------+ | +-----------------SUBJ:V-N----------------+----------------------OBJ:V-N----------------------+ | +--------------SUBJ:V-N-------------+ +------------COMP:V-N(by)-----------+ | +--MOD_ATT:N-ADJ--+ +-------COMP:N-N(of)-------+ | | +------MOD_ATT:N-N------+ | | +MOD_ATT:N-+-------APPOS------+ +--MOD_ATT:N-N--+ | +-MOD_ATT:N-ADJ+ | | | +MOD_ATT:N-ADJ+ | | | +MOD_+ +MOD_ATT:+ | +MOD_ATT:+ | | +MOD_AT+ | | | | +MOD_A+ +MOD_ATT+ | | | | | | | | | | | | | | | | | | | | | In __SP__ glioma cell lines , Sb202190 decreases ( in a dose dependent manner ) expression of __SP__ __NODE__ mRNA that is increased by agonist monoclonal anti __SP__ __NODE__ protein antibody . MOD_ATT:N-ADJ (line,__SP__) MOD_ATT:N-N (line,glioma) MOD_ATT:N-N (line,cell) APPOS (line,decrease) MOD_ATT:N-N (decrease,Sb202190) MOD_ATT:N-N (manner,dose) MOD_ATT:N-ADJ (manner,dependent) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (be,expression) COMP:V-N(In) (increase,line) SUBJ:V-N (increase,expression) COMP:V-N(by) (increase,__SP__) OBJ:V-N (increase,protein) MOD_ATT:N-N (__SP__,agonist) MOD_ATT:N-ADJ (__SP__,monoclonal) MOD_ATT:N-N (__SP__,anti) MOD_ATT:N-ADJ (protein,__NODE__)